There probably is an advantage if a subject, especially in the field of therapy, is controversial. But when physicians cannot agree on whether or not to use a medical procedure, it runs the risk of falling into disuse by some and of being regarded in a suspicious light by others. The literature concerning the intravenous use of electrolytes in the treatment of asthma leaves one with a critical view. It is important, therefore, to gather up the procedures which have proved to be useful and to point out those features of intravenous therapy in severe asthma that should be retained as valuable adjuncts of treatment.
One of the first reports on the intravenous use of dextrose in asthma was by Schafir,1 who in 1927 gave small doses of hypertonic solutions of dextrose intravenously over a period of days to asthmatic patients. Not only was the asthma controlled, but the
SHELDON JM. INTRAVENOUS USE OF FLUIDS IN BRONCHIAL ASTHMA. JAMA. 1949;139(8):506–507. doi:10.1001/jama.1949.02900250010003
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: